Mologen AG (XETRA:MGNK)

European company
add to virtual portfolio
trade
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - MGNK

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - MGNK

  • Market Cap€0.000m
  • SymbolXETRA:MGNK
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINDE000A2LQ900

Company Profile

Mologen AG is a Germany based biotechnology company. It is principally engaged in the research, development, and marketing of products in the area of molecular medicine. The company's primary focus is on oncology and severe infectious diseases. The focus of the research is the dSLIM technologies, which facilitate the use of DNA as a drug for diseases that were previously untreatable. The product pipeline of the organization includes Lefitolimod and EnanDIM.Mologen AG is a Germany based biotechnology company. It is principally engaged in the research, development and marketing of products in molecular medicine. The company’s primary focus is on oncology and severe infectious diseases.

Latest MGNK news

Currently there for this company. Visit our news hub for other news .